Personalized Inhaled Bacteriophage Therapy Shows Promise for Cystic Fibrosis: Study Dr Riya Dave18 Jun 2025 8:30 PM ISTA small study published in Nature Medicine reported encouraging results for personalized inhaled bacteriophage therapy in treating cystic fibrosis...
New Nanoparticles Therapy for Patients with Lung Cancer, Cystic Fibrosis: Study Finds Dr. Bhumika Maikhuri14 Jun 2025 8:15 AM ISTNew Delhi: For treating respiratory diseases, scientists have developed a new drug delivery system that transports genetic therapies directly to the...
New guidelines aim to improve cystic fibrosis screening Dr. Kamal Kant Kohli6 April 2025 9:00 PM ISTAll states should adopt updated screening protocols so more newborns with cystic fibrosis can be diagnosed in the first weeks of life, when...
Meconium-Related Obstruction in Newborns occurs mostly without cystic fibrosis or Hirschsprung disease: JAMA Dr Riya Dave25 Feb 2025 10:30 PM ISTResearchers have found in a new study that contrary to popular belief nearly 95% of meconium-related obstruction (MRO) cases occur without cystic...
Women less likely to get lung transplant than men and they wait longer for surgery, reveals research Dr. Kamal Kant Kohli24 Jan 2025 8:30 PM ISTWomen are less likely to receive a lung transplant and spend an average of six weeks longer on the waiting list, according to a study published in ERJ...
Lupin Cystic fibrosis drug gets tentative approval from USFDA Ruchika Sharma10 Jan 2025 2:30 PM ISTIvacaftor Oral Granules, 25 mg, 50 mg and 75 mg per unit dose packet are indicated for cystic fibrosis treatment in patients aged 4 months and older.
Azithromycin therapy shows positive effect on lung perfusion in infants with cystic fibrosis, finds research Jacinthlyn Sylvia24 Dec 2024 3:00 AM ISTA new study published in the Journal of Cystic Fibrosis found that infants with cystic fibrosis who get azithromycin exhibit a decrease in the...
FDA approves Alyftrek once-daily oral combination for cystic fibrosis Dr. Kamal Kant Kohli23 Dec 2024 8:45 AM ISTThe US Food and Drug Administration has approved Alyftrek, a once-daily oral combination of vanzacaftor, tezacaftor, and deutivacaftor, for the...
ERS Conference Highlights: ChatGPT Surpassed Trainee Doctors in Assessing Complex Respiratory Illness In Children Dr. Garima Soni10 Sept 2024 8:45 AM ISTThe chatbot ChatGPT performed better than trainee doctors in assessing complex cases of respiratory disease in areas such as cystic fibrosis, asthma,...
ChatGPT outperforms trainee doctors in assessing complex respiratory illness in children, reveals research Dr. Kamal Kant Kohli9 Sept 2024 8:00 PM ISTThe chatbot ChatGPT performed better than trainee doctors in assessing complex cases of respiratory disease in areas such as cystic fibrosis, asthma...
Ivacaftor Safe and Effective for Infants with Cystic Fibrosis Aged 1 to <4 Months, reveals study Dr Riya Dave19 July 2024 9:00 PM ISTIn an open-label phase 3 study, researchers report that ivacaftor (IVA) is safe and effective in treating cystic fibrosis in infants aged 1 to less...
Repeated GA Shows No Negative Neurobehavioral Effects in Children with Cystic Fibrosis, suggests Lancet study Dr Riya Dave19 Jun 2024 8:00 AM ISTResearchers have found that repeated exposure to general anesthesia does not negatively impact neurobehavioral outcomes in children with cystic...
